About Pacific Biomarkers
Pacific Biomarkers is a premier biomarker laboratory services provider in the Drug Development Industry supporting preclinical and Phase I-IV studies. Since 1989, Pacific Biomarkers has partnered with the Pharmaceutical, Biotech and Diagnostic Manufacturing Industries to provide biomarker laboratory services. Due to these partnerships and our ability to adapt biomarkers to support compound development we have optimized study outcomes, decreased sponsors' timelines for FDA approval, and provided competitive product differentiation.
Pacific Biomarkers has an established reputation for expertise, flexibility, protocol consultation, and outstanding client services that has propelled the company to a prominent position in the rapidly growing pharmaceutical outsourcing industry. With an extensive network of scientific, regulatory, and technology expertise, Pacific Biomarkers is the service provider of choice for many leading international drug manufacturers in the race to bring products to market as quickly and cost effectively as possible.
Pacific Biomarkers provides accurate, reliable analyses, and responsive service to sponsors and investigative sites. Pacific Biomarkers collaborates with sponsors to develop, validate, improve analytical methods, and provides technical consultation for protocol design. Our services are customized on a project specific basis which allows Pacific Biomarkers to be more flexible to meet the needs of our clients.
Pacific Biomarkers is CAP accredited and CLIA certified. Pacific Biomarkers also provides GLP compliant biomarker laboratory services.